Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies

被引:74
作者
Maggioni, M
Coggi, G
Cassani, B
Bianchi, P
Romagnoli, S
Mandelli, A
Borzio, M
Colombo, P
Roncalli, M
机构
[1] Osped San Paolo, Azienda Osped, Dept Pathol, Cattedra Anat Patol 2, I-20146 Milan, Italy
[2] Univ Milan, Dept Pathol, Humanitas Clin Inst, Milan, Italy
[3] Fatebenefratelli Hosp, Dept Med, Milan, Italy
关键词
D O I
10.1053/jhep.2000.18425
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The genetic profile of dysplastic hepatocellular nodules arising in cirrhosis is poorly understood. We assessed loss of heterozygosity (LOH) and microsatellite instability (MI) in 10 dysplastic nodules (4 low-grade and 6 high-grade) with surrounding cirrhosis and in 10 hepatocellular carcinomas (HCC). Six microsatellite loci were selected and investigated on microdissected needle biopsies. Twenty-four (24.4%) informative loci showed allelic loss, while MI was seen in 3 loci only (3%). The most involved sites were located on chromosomes 4q (54.5%) and 8p (50%), LOH was documented in 16.6%, cirrhotic, 50% low-grade dysplastic nodules (LGDN), 83% high-grade dysplastic nodules (HGDN), and 70% malignant nodules. LOH at multiple loci was increasingly seen from cirrhotic to HGDN, but not from the latter to HCC. The fractional allelic loss (FAL) was significantly increased in dysplastic and neoplastic nodules as compared with cirrhosis (P <.01). The progressive accumulation of genetic changes in cirrhotic, dysplastic, and malignant hepatocellular nodules is in keeping with a multistep process of carcinogenesis; within this spectrum, HGDN can be considered advanced precursors of HCC.
引用
收藏
页码:942 / 946
页数:5
相关论文
共 33 条
[1]   Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver [J].
Aihara, T ;
Noguchi, S ;
Miyoshi, Y ;
Nakano, H ;
Sasaki, Y ;
Nakamura, Y ;
Monden, M ;
Imaoka, S .
HEPATOLOGY, 1998, 28 (01) :86-89
[2]   Clonal analysis of precancerous lesion of hepatocellular carcinoma [J].
Aihara, T ;
Noguchi, S ;
Sasaki, Y ;
Nakano, H ;
Monden, M ;
Imaoka, S .
GASTROENTEROLOGY, 1996, 111 (02) :455-461
[3]  
Ashida K, 1997, J CANCER RES CLIN, V123, P489
[4]  
Boige V, 1997, CANCER RES, V57, P1986
[5]   Ultrasonography-detected macroregenerative nodules in cirrhosis: A prospective study [J].
Borzio, M ;
Borzio, F ;
Croce, A ;
Sala, M ;
Salmi, A ;
Leandro, G ;
Bruno, S ;
Roncalli, M .
GASTROENTEROLOGY, 1997, 112 (05) :1617-1623
[6]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[7]  
Canzian F, 1996, CANCER RES, V56, P3331
[8]   LOSS OF HETEROZYGOSITY IN LIVER-TUMORS [J].
DING, SF ;
HABIB, NA .
JOURNAL OF HEPATOLOGY, 1995, 22 (02) :230-238
[9]   PROPOSAL FOR STANDARDIZED CRITERIA FOR THE DIAGNOSIS OF BENIGN, BORDERLINE, AND MALIGNANT HEPATOCELLULAR LESIONS ARISING IN CHRONIC ADVANCED LIVER-DISEASE [J].
FERRELL, LD ;
CRAWFORD, JM ;
DHILLON, AP ;
SCHEUER, PJ ;
NAKANUMA, Y .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (11) :1113-1123
[10]   MUTATIONAL HOTSPOT IN THE P53 GENE IN HUMAN HEPATOCELLULAR CARCINOMAS [J].
HSU, IC ;
METCALF, RA ;
SUN, T ;
WELSH, JA ;
WANG, NJ ;
HARRIS, CC .
NATURE, 1991, 350 (6317) :427-428